Status:
COMPLETED
Culturally-Tailored Approach to Improve Medication Use in Patients With Heart Attacks
Lead Sponsor:
Johns Hopkins University
Conditions:
Coronary Arteriosclerosis
Myocardial Infarction
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Our research aims to improve the use of medicines known to prevent recurrent heart attacks. In particular, we know that statin treatment is useful after heart attacks, but many patients do not use it....
Detailed Description
The lipid-specific and pleiotropic benefits of statin therapy, and secondary prevention of coronary artery disease (CAD) mortality have been demonstrated. Statin therapy in particular is underutilized...
Eligibility Criteria
Inclusion
- Admitted to Johns Hopkins Hospital or Johns Hopkins Bayview Medical Center
- Diagnoses of Myocardial Infarction, unstable angina, percutaneous intervention, coronary artery bypass surgery
- One of the following:
- Less than a high school education (defined as completion of the 12th grade)
- No insurance for medications with a household income of $50,000. or less
- Any difficulty in co-pay even with a household income of \>$50,000.
Exclusion
- physician contraindicates statin use
- chronic glucocorticosteroid therapy
- autoimmune disease (i.e. lupus erythematosus)
- current chemotherapy or radiation
- immediate life-threatening comorbidity (i.e. HIV-AIDS, end-stage renal disease, or cancer)
- history of hepatic or renal failure
- myositis with creatine kinase (CK) elevations
- any prior adverse response to statin therapy
- statin allergy
- rhabdomyolysis
- pregnant women
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT00426231
Start Date
March 1 2006
End Date
December 1 2009
Last Update
February 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21205